209 related articles for article (PubMed ID: 17968620)
1. Factors limiting complete tumor ablation by radiofrequency ablation.
Paulet E; Aubé C; Pessaux P; Lebigot J; Lhermitte E; Oberti F; Ponthieux A; Calès P; Ridereau-Zins C; Pereira PL
Cardiovasc Intervent Radiol; 2008; 31(1):107-15. PubMed ID: 17968620
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
[TBL] [Abstract][Full Text] [Related]
3. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
[TBL] [Abstract][Full Text] [Related]
4. [Radiofrequency ablation of malignant liver tumors: use of a volumetric necrosis-tumor ratio for local control].
Kühl H; Stattaus J; Kühl B; Boes T; Antoch G; Frilling A; Forsting M
Rofo; 2006 Dec; 178(12):1243-9. PubMed ID: 17136648
[TBL] [Abstract][Full Text] [Related]
5. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
6. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors.
Jiao LR; Hansen PD; Havlik R; Mitry RR; Pignatelli M; Habib N
Am J Surg; 1999 Apr; 177(4):303-6. PubMed ID: 10326848
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of contrast-enhanced US versus CT or MRI for the therapeutic control of percutaneous radiofrequency ablation in the case of hepatic malignancies.
Frieser M; Kiesel J; Lindner A; Bernatik T; Haensler JM; Janka R; Hahn EG; Strobel D
Ultraschall Med; 2011 Apr; 32(2):148-53. PubMed ID: 21225567
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
[TBL] [Abstract][Full Text] [Related]
9. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence.
Ayav A; Germain A; Marchal F; Tierris I; Laurent V; Bazin C; Yuan Y; Robert L; Brunaud L; Bresler L
Am J Surg; 2010 Oct; 200(4):435-9. PubMed ID: 20409524
[TBL] [Abstract][Full Text] [Related]
11. [Radiofrequency of the liver - an update].
Bangard C
Rofo; 2011 Aug; 183(8):704-13. PubMed ID: 21318934
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
[TBL] [Abstract][Full Text] [Related]
15. [Radiofrequency ablation in primary and secondary liver tumors].
Carditello A; Scisca C; David A; Stilo F; Basile M
Chir Ital; 2002; 54(1):83-6. PubMed ID: 11942016
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
[TBL] [Abstract][Full Text] [Related]
17. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
Hoffman AL; Wu SS; Obaid AK; French SW; Lois J; McMonigle M; Ramos HC; Sher LS; Lopez RR
Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
[TBL] [Abstract][Full Text] [Related]
18. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
[TBL] [Abstract][Full Text] [Related]
19. [Application of contrast-enhanced ultrasonography in selecting indication of radiofrequency ablation among hepatocellular carcinoma patients].
Chen MH; Wu W; Yang W; Gao W; Dai Y; Yin SS; Huo L; Yan K
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3491-4. PubMed ID: 16686066
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.
Lyrdal D; Andersson M; Hellström M; Sternal J; Lundstam S
Acta Radiol; 2010 Sep; 51(7):808-18. PubMed ID: 20707665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
